These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25691648)

  • 1. Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice.
    Retamal M; Abed Y; Rhéaume C; Cappelletti F; Clementi N; Mancini N; Clementi M; Burioni R; Boivin G
    Antimicrob Agents Chemother; 2015 May; 59(5):2647-53. PubMed ID: 25691648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes.
    Clementi N; De Marco D; Mancini N; Solforosi L; Moreno GJ; Gubareva LV; Mishin V; Di Pietro A; Vicenzi E; Siccardi AG; Clementi M; Burioni R
    PLoS One; 2011; 6(12):e28001. PubMed ID: 22162996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    Shen W; Wang Q; Wang Z; Liu M; Du Y; Yuan L; Han L; Smietanka K; Chen H; Xu S; Zhu Q
    J Virol; 2022 Sep; 96(18):e0123822. PubMed ID: 36037479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect.
    Nagai T; Urata M; Yamada H
    Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A; Abed Y; Rhéaume C; Boivin G
    Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies.
    Vigil A; Frias-Staheli N; Carabeo T; Wittekind M
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
    Baranovich T; Jones JC; Russier M; Vogel P; Szretter KJ; Sloan SE; Seiler P; Trevejo JM; Webby RJ; Govorkova EA
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2118-31. PubMed ID: 26787699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.
    Leyva-Grado VH; Tan GS; Leon PE; Yondola M; Palese P
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4162-72. PubMed ID: 25941218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation, characterization, and protective ability of mouse monoclonal antibodies against the HA of A (H1N1) influenza virus.
    Wang L; Yang F; Xiao Y; Chen B; Liu F; Cheng L; Yao H; Wu N; Wu H
    J Med Virol; 2022 Jun; 94(6):2558-2567. PubMed ID: 35005794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
    Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
    Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
    Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z
    Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates.
    Song A; Myojo K; Laudenslager J; Harada D; Miura T; Suzuki K; Kuni-Kamochi R; Soloff R; Ohgami K; Kanda Y
    Antiviral Res; 2014 Nov; 111():60-8. PubMed ID: 25218949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
    Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes.
    Chen Y; Wang F; Yin L; Jiang H; Lu X; Bi Y; Zhang W; Shi Y; Burioni R; Tong Z; Song H; Qi J; Gao GF
    Nat Commun; 2022 Dec; 13(1):7603. PubMed ID: 36494358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.
    Wei CJ; Yassine HM; McTamney PM; Gall JG; Whittle JR; Boyington JC; Nabel GJ
    Sci Transl Med; 2012 Aug; 4(147):147ra114. PubMed ID: 22896678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of lethal influenza A virus bronchopneumonia in mice by monoclonal antibody against haemagglutinin stem region.
    Lipatov AS; Gitelman AK; Smirnov YuA
    Acta Virol; 1997 Dec; 41(6):337-40. PubMed ID: 9607093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus.
    Marathe BM; Asthagiri Arunkumar G; Vogel P; Pascua PNQ; Jones J; Webby RJ; Krammer F; Govorkova EA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice.
    Choi HJ; Song JH; Kwon DH
    Phytother Res; 2012 Mar; 26(3):462-4. PubMed ID: 21728202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro.
    Chen JX; Xue HJ; Ye WC; Fang BH; Liu YH; Yuan SH; Yu P; Wang YQ
    Biol Pharm Bull; 2009 Aug; 32(8):1385-91. PubMed ID: 19652378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.